PAH

Deep dive into Actelion's Uptravi data calms investors as FDA decision date nears
Fierce Biotech
Wed, 03/18/15 - 11:08 am
Actelion
Uptravi
PAH
pulmonary arterial hypertension
Drug-device biotech SteadyMed swings for a $55M IPO
Fierce Biotech
Mon, 02/9/15 - 09:07 pm
devices
SteadyMed
IPOs
biotech
PAH
GSK and Gilead’s combination therapy: positive results in PAH
Pharmaphorum
Tue, 09/9/14 - 10:36 am
GSK
Gilead Sciences
PAH
pulmonary arterial hypertension
Letairis
Adcirca
Arena Pharmaceuticals' APD811 Gets Orphan Drug Status
Yahoo/Zacks.com
Thu, 09/4/14 - 08:01 am
Arena Pharmaceuticals
APD811
orphan drugs
PAH
pulmonary arterial hypertension
Actelion’s Lung Drug May Face Study Against Gilead Rival
Bloomberg
Wed, 02/12/14 - 09:50 am
Actelion
Gilead Sciences
Opsumit
Letairis
PAH
pulmonary arterial hypertension
Actelion gets second boost for Opsumit with EU approval
Fierce Pharma
Mon, 12/23/13 - 03:23 pm
Actelion
Opsumit
Europe
Tracleer
PAH
pulmonary arterial hypertension
United Therapeutics Shares Gain on FDA Hypertension Approval
Bloomberg
Mon, 12/23/13 - 11:27 am
FDA
United Therapeutics
PAH
pulmonary arterial hypertension
Did One Of The Top 10 Upside Surprises In The History Of The Biotech Sector Just Happen?
Forbes
Mon, 12/23/13 - 10:22 am
Remodulin
PAH
pulmonary arterial hypertension
Orenitram
United Therapeutics
United Therapeutics receives subpoena for 3 drugs
Yahoo/AP
Mon, 12/9/13 - 10:09 am
United Therapeutics
PAH
Remodulin
Tyvaso
Adcirca
pulmonary arterial hypertension
Actelion hits 6-yr high after favourable FDA approval for drug
Yahoo/Reuters
Mon, 10/21/13 - 08:36 am
FDA
Actelion
Opsumit
PAH
Actelion Wins U.S. FDA Approval for Lung Disorder Therapy
Bloomberg
Fri, 10/18/13 - 05:47 pm
Actelion
FDA
Opsumit
PAH
Patient in Arena lung drug trial experiences heart problem
Reuters
Thu, 08/29/13 - 10:27 am
Arena Pharmaceuticals
APD811
PAH
pulmonary arterial hypertension
Arena Pharmaceuticals' candidate for pulmonary hypertension completes Phase 1b
Yahoo/Fly on the Wall
Wed, 08/28/13 - 10:45 am
PAH
pulmonary arterial hypertension
Arena Pharmaceuticals
APD811
United Therapeutics' Second PAH Stumble Emphasizes The Need For Pluristem's Therapy
Seeking Alpha
Tue, 04/30/13 - 08:37 am
United Therapeutics
PAH
pulmonary arterial hypertension
Remodulin
Pluristem Therapeutics
Actelion Looks Within as Competition Lifts Drug Prices
Bloomberg
Mon, 02/18/13 - 12:24 pm
Actelion
pulmonary arterial hypertension
PAH
Tracleer
Bayer Seeks Riociguat Approval
Yahoo/Zacks
Wed, 02/13/13 - 10:22 am
Bayer
Riociguat
PAH
pulmonary arterial hypertension
Watson to sell generic version of Pfizer's Revatio
Yahoo/AP
Mon, 11/12/12 - 12:25 pm
Pfizer
generics
Watson Pharmaceuticals
Revatio
pulmonary arterial hypertension
PAH
Detailed data supports Actelion's big lung drug hope
Reuters
Wed, 10/24/12 - 12:05 pm
Actelion
macitentan
PAH
United Therapeutics Falls as FDA Rejects Oral Remodulin
Bloomberg
Wed, 10/24/12 - 11:43 am
FDA
Remodulin
United Therapeutics
PAH
Bayer lung drug shows promise in pulmonary hypertension
Reuters
Mon, 10/22/12 - 12:09 pm
Bayer
PAH
Actelion
Gilead
Riociguat
Tracleer

Pages